How much has Hippocratic AI raised?

Hippocratic AI is best read as a private healthcare ai agents company with $404M in public funding history. Public funding databases and company releases do not always classify strategic upfronts, debt, and equity the same way, so this profile separates disclosed equity funding from business-development economics where relevant.

Public investors include Andreessen Horowitz and other venture or growth investors named in the linked funding releases. The investor base should be read as a signal of venture-scale expectations, not proof of current profitability.

$3.5B latest disclosed valuation. The valuation moved with company scale, category momentum, investor demand, and the company's ability to expand beyond its initial product wedge.

Hippocratic AI has not disclosed audited profitability or a formal IPO timetable in the sources reviewed. Treat any IPO discussion as speculative until the company files or announces plans.

Hippocratic AI's funding supports enterprise-grade buying when a vendor maps to current priorities. Strong angles are efficiency, compliance, reliability, data quality, workflow adoption, and measurable revenue or customer impact.